Reckitt Benckiser Group PLC
Company Profile
Business description
Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded as Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold a number-one or -two position in their categories globally. Reckitt has repositioned its portfolio; it entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating over 40% of core sales from emerging markets.
Contact
103-105 Bath Road
SloughBerkshireSL1 3UH
GBRT: +44 1753217800
Sector
Consumer Defensive
Stock type
Defensive
Industry
Household & Personal Products
Fiscal Year End
31 December 2026
Employees
36,200
Reckitt Benckiser Group PLC News & Analysis
stocks
The 10 best global companies to invest in now
stocks
Best international companies to own: 2023 Edition
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,692.80 | 143.80 | -1.63% |
| CAC 40 | 7,927.75 | 152.99 | -1.89% |
| DAX 40 | 24,802.78 | 661.03 | -2.60% |
| Dow JONES (US) | 48,147.33 | 949.73 | -1.93% |
| FTSE 100 | 10,346.34 | 106.34 | -1.02% |
| HKSE | 22,410.80 | 430.82 | -1.89% |
| NASDAQ | 22,617.73 | 1,261.47 | -5.28% |
| Nikkei 225 | 56,436.65 | 3,007.56 | -5.06% |
| NZX 50 Index | 14,107.41 | 139.84 | -0.98% |
| S&P 500 | 6,910.39 | 265.44 | -3.70% |
| S&P/ASX 200 | 8,592.60 | 137.80 | -1.58% |
| SSE Composite Index | 3,533.79 | 43.82 | -1.22% |